Duration of adjuvant chemotherapy for colon cancer and survival among the elderly.

PubWeight™: 2.26‹?› | Rank: Top 2%

🔗 View Article (PMID 16618946)

Published in J Clin Oncol on April 17, 2006

Authors

Alfred I Neugut1, Matthew Matasar, Xiaoyan Wang, Russell McBride, Judith S Jacobson, Wei-Yann Tsai, Victor R Grann, Dawn L Hershman

Author Affiliations

1: Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, New York, NY 10032, USA. ain1@columbia.edu

Articles citing this

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol (2010) 4.43

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat (2010) 3.35

Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA (2010) 2.93

Socioeconomic and other predictors of colonoscopy preparation quality. Dig Dis Sci (2010) 2.04

The impact of comorbidity on cancer survival: a review. Clin Epidemiol (2013) 1.68

Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer. Gynecol Oncol (2015) 1.43

Challenges in the management of older patients with colon cancer. J Natl Compr Canc Netw (2012) 1.09

Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients. Br J Cancer (2007) 1.05

Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis. Cancer (2012) 1.05

Differences in the therapeutic approach to colorectal cancer in young and elderly patients. Oncologist (2012) 1.01

Feasibility study of alternate-day S-1 as adjuvant chemotherapy for gastric cancer: a randomized controlled trial. Gastric Cancer (2013) 1.01

Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network. Cancer (2012) 0.97

Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems. BMC Cancer (2008) 0.93

Patterns of colorectal cancer care in the United States and Canada: a systematic review. J Natl Cancer Inst Monogr (2013) 0.93

Safety analysis of two different regimens of uracil-tegafur plus leucovorin as adjuvant chemotherapy for high-risk stage II and III colon cancer in a phase III trial comparing 6 with 18 months of treatment: JFMC33-0502 trial. Cancer Chemother Pharmacol (2014) 0.86

Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans. BMC Cancer (2015) 0.85

Patterns of Colorectal Cancer Care in the United States: 1990-2010. J Natl Cancer Inst (2015) 0.85

Comorbidity in older adults with cancer. J Geriatr Oncol (2015) 0.85

Uptake of oxaliplatin and bevacizumab for treatment of node-positive and metastatic colon cancer. J Oncol Pract (2012) 0.83

Colorectal cancer treatment in older patients. Gastrointest Cancer Res (2007) 0.82

Screening mammography use and chemotherapy among female stage II colon cancer patients: a retrospective cohort study. BMC Health Serv Res (2010) 0.81

Systemic therapy for elderly patients with gastrointestinal cancer. Clin Med Insights Oncol (2011) 0.80

Long-term survival benefits of adjuvant chemotherapy by decreasing incidence of tumor recurrence without delaying relapse in stage III colorectal cancer. Int J Colorectal Dis (2011) 0.79

Assessment of solid cancer treatment feasibility in older patients: a prospective cohort study. Oncologist (2014) 0.79

Evaluation of biodistribution and safety of adenovirus vector containing MDR1 in mice. J Exp Clin Cancer Res (2010) 0.78

Feasibility study of S-1 adjuvant chemotherapy in patients with colorectal cancer. Int J Clin Oncol (2012) 0.77

Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502. Ann Oncol (2015) 0.77

Patterns of Treatment Sequences in Chemotherapy and Targeted Biologics for Metastatic Colorectal Cancer: Findings from a Large Community-Based Cohort of Elderly Patients. Drugs Real World Outcomes (2016) 0.75

Adjuvant Chemotherapy for Advanced Gastric Cancer in Elderly and Non-elderly Patients: Meta-Analysis of Randomized Controlled Trials. Cancer Res Treat (2016) 0.75

Optimal schedule of adjuvant chemotherapy with S-1 for stage III colon cancer: study protocol for a randomized controlled trial. Trials (2013) 0.75

Optimal duration of fluorouracil-based adjuvant chemotherapy for patients with resectable gastric cancer. PLoS One (2013) 0.75

Individual- and neighborhood-level predictors of mortality in Florida colorectal cancer patients. PLoS One (2014) 0.75

Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: Tolerability and prognostic factors. Exp Ther Med (2010) 0.75

Colorectal cancer treatment in the elderly: tailored therapy approaches. Gastrointest Cancer Res (2007) 0.75

Does shorter duration of chemotherapy worsen survival for elderly patients with colon cancer? Nat Clin Pract Oncol (2007) 0.75

Trans-sectoral care in patients with colorectal cancer: Protocol of the randomized controlled multi-center trial Supportive Cancer Care Networkers (SCAN). BMC Cancer (2015) 0.75

The evidence for adjuvant treatment of elderly patients (age > or = 70) with stage III colon cancer is inconclusive. Surg Today (2010) 0.75

Impact of chemotherapy-related prognostic factors on long-term survival in patients with stage III colorectal cancer after curative resection. Int J Clin Oncol (2012) 0.75

Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma. Oncologist (2017) 0.75

Articles by these authors

Traces of human migrations in Helicobacter pylori populations. Science (2003) 11.92

Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med (2008) 6.80

Effects of transplacental exposure to environmental pollutants on birth outcomes in a multiethnic population. Environ Health Perspect (2003) 5.66

Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst (2009) 5.62

Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution. Nat Genet (2002) 5.37

Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst (2007) 4.97

Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. JAMA (2013) 4.67

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol (2010) 4.43

Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol (2007) 3.92

Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst (2003) 3.71

Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol (2005) 3.02

High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol (2009) 2.97

Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol (2005) 2.85

Distinguishing human ethnic groups by means of sequences from Helicobacter pylori: lessons from Ladakh. Proc Natl Acad Sci U S A (2004) 2.83

Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol (2007) 2.69

Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial. JAMA (2010) 2.67

Effect of prenatal exposure to airborne polycyclic aromatic hydrocarbons on neurodevelopment in the first 3 years of life among inner-city children. Environ Health Perspect (2006) 2.63

Comparative effectiveness of robotic versus laparoscopic hysterectomy for endometrial cancer. J Clin Oncol (2012) 2.59

MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. Int J Oncol (2011) 2.59

International studies of prenatal exposure to polycyclic aromatic hydrocarbons and fetal growth. Environ Health Perspect (2006) 2.44

Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer (2006) 2.36

Issues in the design of a clinical trial with a behavioral intervention--the Zambia exclusive breast-feeding study. Control Clin Trials (2004) 2.36

Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis (2005) 2.32

Comparison of survival outcomes among cancer patients treated in and out of clinical trials. J Natl Cancer Inst (2014) 2.30

Comparing genetic ancestry and self-described race in african americans born in the United States and in Africa. Cancer Epidemiol Biomarkers Prev (2008) 2.29

Facilitating cancer research using natural language processing of pathology reports. Stud Health Technol Inform (2004) 2.28

Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat (2006) 2.26

Trends in relative survival for ovarian cancer from 1975 to 2011. Obstet Gynecol (2015) 2.22

Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. J Clin Oncol (2005) 2.11

Immune-related microRNAs are abundant in breast milk exosomes. Int J Biol Sci (2011) 2.11

Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstet Gynecol (2013) 2.05

Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial. Lancet Infect Dis (2012) 2.05

Role of extracellular superoxide dismutase in the mouse angiotensin slow pressor response. Hypertension (2006) 2.05

Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol (2011) 2.00

Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol (2012) 1.98

Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol (2002) 1.93

Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med (2002) 1.89

Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans. Blood (2012) 1.85

Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol (2008) 1.83

Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol Cell Proteomics (2011) 1.81

Focal adhesion kinase is required for intestinal regeneration and tumorigenesis downstream of Wnt/c-Myc signaling. Dev Cell (2010) 1.79

Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Cancer (2005) 1.78

Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys (2006) 1.77

Trends in hospital volume and patterns of referral for women with gynecologic cancers. Obstet Gynecol (2013) 1.72

Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer. J Clin Oncol (2010) 1.71

Use of complementary and alternative medicine among United States adults: the influences of personality, coping strategies, and social support. Prev Med (2005) 1.70

Elevations in mortality associated with weaning persist into the second year of life among uninfected children born to HIV-infected mothers. Clin Infect Dis (2010) 1.70

Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst (2003) 1.68

Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis. J Clin Oncol (2002) 1.68

Perivascular support of human hematopoietic stem/progenitor cells. Blood (2013) 1.67

Molecular evidence of an interaction between prenatal environmental exposures and birth outcomes in a multiethnic population. Environ Health Perspect (2004) 1.66

Defining the limits of radical cytoreductive surgery for ovarian cancer. Gynecol Oncol (2011) 1.66

The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study. Breast Cancer Res Treat (2009) 1.66

CTLA4 blockade broadens the peripheral T-cell receptor repertoire. Clin Cancer Res (2014) 1.66

Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents. Breast Cancer Res Treat (2010) 1.65

The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy. Breast J (2012) 1.64

High uptake of exclusive breastfeeding and reduced early post-natal HIV transmission. PLoS One (2007) 1.62

Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. Br J Haematol (2008) 1.61

T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J Hepatol (2010) 1.60

Effect of surgical volume on outcomes for laparoscopic hysterectomy for benign indications. Obstet Gynecol (2012) 1.58

Incidence and predictors of bowel obstruction in elderly patients with stage IV colon cancer: a population-based cohort study. JAMA Surg (2013) 1.57

Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation. Ann Intern Med (2006) 1.57

Trends in surgical mesh use for pelvic organ prolapse from 2000 to 2010. Obstet Gynecol (2012) 1.55

Salvage-targeted kidney cancer therapy in patients progressing on high-dose interleukin-2 immunotherapy: the UCLA experience. Cancer J (2013) 1.52

Antioxidants and cancer therapy: a systematic review. J Clin Oncol (2004) 1.51

A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. J Immunol (2010) 1.51

Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. J Natl Cancer Inst (2010) 1.50

Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev (2002) 1.48

Patient income level and cancer clinical trial participation. J Clin Oncol (2013) 1.48

Variation in ovarian conservation in women undergoing hysterectomy for benign indications. Obstet Gynecol (2013) 1.46

Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis. J Clin Oncol (2002) 1.44

The effects of low-dose fentanyl on emergence agitation and quality of life in patients with moderate developmental disabilities. J Clin Anesth (2005) 1.44

Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma. J Clin Oncol (2008) 1.44